Skip to search formSkip to main contentSkip to account menu

FCE 24517

Known as: FCE-24517 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
We have developed a stable line of the human breast carcinoma cell line MCF-7 by in vitro continuous exposure to increasing… 
1998
1998
Tallimustine [PNU 152241 (FCE 24517)] is a synthetic derivative of the DNA minor groove binder distamycin A, in which the NH2… 
1996
1996
Alkylating distamycin derivative FCE-24517 (l) is the prototype of a novel class of alkylating agents. In the present study we… 
1994
1994
The role of alkylation of the N3 position of adenine in the cytotoxicity of alkylating agents in mammalian cells is still… 
1993
1993
Human colon adenocarcinoma cells (LoVo) resistant to the new antitumor agent FCE 24517 [benzoyl-mustard derivative of distamycin… 
1993
1993
Intracellular glutathione (GSH) content was measured by flow cytometry using monochlorobimane (mBCI) and by the enzymatic assay… 
1992
1992
Highly Cited
1991
Highly Cited
1991
N-Deformyl-N-(4-N-N,N-bis(2-chloroethylamino)benzoyl)distamy cin A (FCE 24517) is a novel cytotoxic and antitumor agent shortly… 
Highly Cited
1991
Highly Cited
1991
FCE 24157 (chemically (beta-[1-methyl-4-(1-methyl-4--[1-methyl-4-(4-N,N- bis(2-chloroethyl) amino-benzene-1-carboxy-amido…